Fund Holdings — First Turn Management, LLC

Total Portfolio Value:
$895.10M
Total Bought:
$200.23M
Total Sold:
$175.42M
Net Transaction:
+$24.81M
Notable People:
Lisa Gable Wheatley, Tracy Austin Murphy, Stephen Allyn Rosetta
Securities
▲▼
SharesValue
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
United Therapeutics Corporation(UTHR)63,580104,726+41,146$30.98M$62.10M6.94%+$31.12M
ABIVAX Société AnonymeADS(ABVX)381,233465,869+84,636$51.41M$51.87M5.80%+$463.3K
BridgeBio Pharma, Inc.(BBIO)595,473695,718+100,245$45.55M$51.66M5.77%+$6.12M
Xenon Pharmaceuticals Inc.(XENE)799,743786,844-12,899$35.84M$45.75M5.11%+$9.91M
Revolution Medicines, Inc.(RVMD)638,385468,376-170,009$50.85M$45.55M5.09%-$5.30M
Apogee Therapeutics Inc474,839513,770+38,931$35.84M$43.24M4.83%+$7.40M
Insmed Incorporated(INSM)264,293248,475-15,818$46.00M$40.63M4.54%-$5.37M
Nuvalent Inc368,697370,344+1,647$37.09M$37.94M4.24%+$854.5K
Mirum Pharmaceuticals, Inc.(MIRM)481,564400,464-81,100$38.04M$36.99M4.13%-$1.04M
Cogent Biosciences, Inc.(COGT)824,283947,339+123,056$29.28M$36.46M4.07%+$7.18M
Roivant Sciences Ltd.SHS(ROIV)1,186,8171,190,118+3,301$25.75M$32.97M3.68%+$7.21M
Axsome Therapeutics, Inc.(AXSM)206,921188,772-18,149$37.79M$31.91M3.56%-$5.89M
IDEAYA Biosciences, Inc.(IDYA)723,653873,838+150,185$25.02M$29.12M3.25%+$4.10M
ORIC Pharmaceuticals, Inc.(ORIC)2,010,3072,017,284+6,977$16.44M$25.56M2.86%+$9.11M
Enliven Therapeutics Inc0623,839+623,839$0$24.45M2.73%+$24.45M
Celcuity Inc.(CELC)0210,578+210,578$0$24.04M2.69%+$24.04M
Scholar Rock Holding Corporation(SRRK)459,727446,390-13,337$20.25M$21.94M2.45%+$1.69M
Kymera Therapeutics, Inc.(KYMR)206,445254,672+48,227$16.06M$21.21M2.37%+$5.15M
Cytokinetics, Incorporated(CYTK)325,668283,700-41,968$20.69M$18.70M2.09%-$1.99M
Dianthus Therapeutics, Inc.(DNTH)0220,921+220,921$0$18.54M2.07%+$18.54M
Palvella Therapeutics, Inc.(PVLA)0148,093+148,093$0$18.46M2.06%+$18.46M
Newamsterdam Pharma Company
ORDINARY SHARES
893,473558,336-335,137$31.34M$17.87M2.00%-$13.47M
Viridian Therapeutics, Inc.(VRDN)690,528911,337+220,809$21.49M$17.83M1.99%-$3.66M
Ascendis Pharma A/SADR(ASND)131,80876,300-55,508$28.11M$17.45M1.95%-$10.65M
Fulcrum Therapeutics, Inc.(FULC)1,892,6832,256,109+363,426$21.41M$17.30M1.93%-$4.10M
Terns Pharmaceuticals Inc872,049326,694-545,355$35.23M$17.22M1.92%-$18.01M
Vera Therapeutics, Inc.CL A(VERA)601,774422,023-179,751$30.47M$16.98M1.90%-$13.50M
Natera, Inc.(NTRA)80,87581,077+202$18.53M$16.21M1.81%-$2.31M
Erasca, Inc.(ERAS)0867,639+867,639$0$14.04M1.57%+$14.04M
Praxis Precision Medicines, Inc.(PRAX)35,74942,441+6,692$10.54M$13.67M1.53%+$3.14M
Olema Pharmaceuticals, Inc.(OLMA)617,714768,662+150,948$15.44M$11.46M1.28%-$3.98M
uniQure N.V.SHS(QURE)321,655615,489+293,834$7.70M$10.06M1.12%+$2.37M
MoonLake ImmunotherapeuticsCL A(MLTX)262,643315,563+52,920$3.46M$5.88M0.66%+$2.42M
Arcus Biosciences, Inc.(RCUS)565,1420-565,142$13.47M$0—-$13.47M
argenx SEADR(ARGX)23,2560-23,256$19.56M$0—-$19.56M
Disc Medicine, Inc.(IRON)153,2060-153,206$12.17M$0—-$12.17M
Guardant Health, Inc.(GH)271,6850-271,685$27.75M$0—-$27.75M
Rhythm Pharmaceuticals, Inc.(RYTM)146,3030-146,303$15.66M$0—-$15.66M
Page 1 of 1
First Turn Management, LLC — 13F Holdings — Q1 2026 | TickerTrail